Corcept Therapeutics
| Use attributes for filter ! | |
| Stock price | CORT |
|---|---|
| Disclaimer | |
| Headquarters | Menlo Park |
| California | |
| United States | |
| Founders | Alan Schatzberg |
| Founded | May 13 |
| 1998 | |
| Subsidiary | Corcept Therapeutics UK Limited |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046045 |
About Corcept Therapeutics
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects.
